News

Researchers warn against heavy use, especially in youth

Advocates and citizens have little hope for drug policy reform from the Biden administration this year

The firm has sold its 25% interest in Belleville Complex Inc. for $10.1 million

But the country's piecemeal approach to reforming drug laws are causing confusion

Ongoing shipments to Focus Medical suggest a high demand for premium flower in the country

GNC has over 4,800 retail locations across America

Registration has opened and the province says products will be showcased 'soon'

Two separate trials will look at MDMA for alcohol use and PTSD, as well as psilocybin-assisted therapy for anorexia nervosa

About 1.3M people in the UK have long Covid

The firm expects the proceeds and funds from operations to be enough to repay its convertible debentures on maturity

If approved, it will mark the firm's first independent clinical trial with a proprietary extract

The largest increase in drivers with moderate injuries was seen in men over 50

The firm is also expecting a first harvest at its Portugal facility this month

The Constitutional Court still needs to issue an opinion and set a date for the vote, which advocates hope could come as early as spring

City council voted Thursday to reduce the licensing fee to $3,500 in 2022 from $5,000 previously

Business licensing fees for cannabis stores are higher than any other category

The new financing deal will delay a vote by Merida shareholders to approve its merger deal with Leafly

The amendment is meant to address insufficient regulations

Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects

The company will be EBITDA-positive by Q3, CEO says

Despite ongoing calls, no social equity provisions have yet to be included in the country's cannabis regulations

For better or for worse, the firm's focus appears to be moving further away from cannabis sales

City council will take the first look at Copilot's business licence application on Monday

The research shows a sharp uptick in young children going to hospital, in the period after legal edibles came to market

Four company directors have immediately resigned

The stronger preference for flower is steady across demographics

Recent regulatory amendments signal greater acceptance of cannabis as medicine in the country

Critics say the move will drive customers to the black market

The money will go toward general business support but also direct capital and startup financing

According to a pilot, 60% of customers preferred using kiosks to buy their cannabis

Similar non-arrest models for shoplifting have shown to be effective in the city

Industry organizations say they've taken action against the new regulations

As of Jan. 1, up to 6M patients can look forward to significantly reduced costs and a simpler application process

The $10M shipment follows an $8M export made last July

The total deal amounts to nearly half of Emerald's market value

It's unclear what will happen with the proposed regulatory framework

Decriminalization was linked to a roughly 17% drop in racial disparity between Black and white adults being arrested

Most licences will be issued without a fixed end date

Psychedelics firm Numinus says amendments made to the country's Special Access Programme come into effect in January

The deal follows two other recent acquisitions in the state